Congress asks FDA chief to testify on J&J recall; Ranbaxy recalls three European product batches;

 @FiercePharma:  Pfizer manufacturing overhaul claims 8 plants, 6,000 jobs. Article | Follow @FiercePharma

> FDA Commissioner Margaret Hamburg has been asked to testify at the May 27 Congressional hearing that will probe Johnson & Johnson's recent recall of more than 40 children's and infants' medications, as new details emerge about the problems with those drugs. Report | Report

> India's Ranbaxy Laboratories said its European unit was recalling select batches of three products to add safety warnings under the regulations there. Report

> A drug approved to treat a range of conditions may also work to prevent lung cancer in people who have given up smoking, U.S. researchers reported. Report

> Pfizer's Revatio, which is identical to Viagra but in different dosage, missed the main goal of a study in an advanced form of a fatal lung disease, although improvements in some symptoms may aid patients that currently have no options. Report

> Sinclair Pharma said the new management's restructuring strategy is driving a significant business turnaround with a strong recovery in its Italian market and a new strategy in France leading a recovery. Report

> Indian CMO Kemwell says new manufacturing plant in Sweden will help meet customer demand for European production capacity. Report

Biotech News

 @FierceBiotech: Biopharma execs predict a big spike in M&A deals. Report | Follow @FierceBiotech

 @JohnCFierce: Pfizer gets Wash U researchers to take a second look at its molecules. Article | Follow @JohnCFierce

> Roche, Biogen shutter blockbuster ocrelizumab arthritis program. Story

> Biotech investors brace for annual ASCO data dump. Report

> NicOx delays a PhII as it deals with NSAID setback. Article

> BIO boosts lobbying efforts in Q1. Report

Drug Delivery News

> Pearl reports inhaled COPD drug results. Item

> Topical HIV/AIDS vax gets nanomedicine formulation. Story

> Obesity pill data demonstrates efficacy. News

> Otonomy presents preclinical hearing loss data. Report

Medical Device News

> GE Healthcare invests $5M in CardioDx. News

> Virtual Radiologic purchased for $294M. Story

> Breathe Technologies secures $23M in financing. Report

> Merit inks merger deal with BioSphere. Item

> CDRH joins Twitter. Story

> Nautic completes Medegen sale to CareFusion. Article

And Finally... Patients whose doctors over-prescribe antibiotics may develop drug resistance that lasts up to a year, putting them and the population at risk when more serious treatment is needed, scientists said. Report